Pfizer’s ex-R&D chief Dolsten withdraws from Novo Nordisk board race
(Reuters) -Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's board, citing personal reasons, ...
Thursday, March 26, 2026
Tag: exRD
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.